Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model
Influenza B virus (IBV) is among the predominant pathogens of the annual influenza epidemic, and the illness burden is important, particularly amongst kids and younger youngsters. On this examine, the antiviral and anti inflammatory results of a conventional Chinese language drugs prescription, the Lianhua-Qingwen capsule, have been evaluated.
Our outcomes confirmed that Lianhua-Qingwen capsule can inhibit each Victoria and Yamagata lineages, and the 50% inhibitive concentrations ranged from 0.228 ± 0.150 to 0.754 ± 0.161 mg/mL.
The time course outcomes demonstrated that IBV yields have been diminished with therapy at 0-Four h after an infection, and the mechanistic analysis verified that Lianhua-Qingwen capsule has hemagglutination inhibition exercise towards B/Guangzhou/0215/2012 however not A/California/04/2009.
Along with antiviral exercise, Lianhua-Qingwen capsule can even inhibit extreme expression of RANTES, IL-6, IL-8, IP-10, TNF-α, MCP-1, MIP-1β, and IFN-λ on the mRNA stage and stop a extreme inflammatory response.
The in vivo outcomes confirmed that orally administered Lianhua-Qingwen capsule (100-400 mg/kg/day) doesn’t cut back IBV-induced lung viral load and mortality in mice.
Nevertheless, the pathological change in lungs was alleviated, and there have been fewer inflammatory cells within the lungs of Lianhua-Qingwen capsule handled mice than these in controls.
by william flowdi
Additional analysis confirmed that the mix therapy of 200 mg/kg/day of Lianhua-Qingwen capsule with 2 mg/kg/day of oseltamivir considerably diminished IBV an infection over the person administration of both alone in vivo.
Washington Biotechnology & Biomedical Association
Our findings show that Lianhua-Qingwen capsule might be used as an assistant drugs to boost the impact of oseltamivir towards influenza B virus an infection.
Should the Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids.
Should the Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids.
Should the Canine Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Canine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Should the Canine Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Canine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Should the Human Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Human Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Should the Human Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Human Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Should the Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids.
Should the Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids.
Should the Rat Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Rat Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Should the Rat Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Rat Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Description: The protein encoded by this gene is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000
Therapeutic anti-psoriatic results of myeloid-derived suppressor cells together with systemic tacrolimus (FK-506) in an imiquimod-induced mouse mannequin of psoriasis
Though tacrolimus (FK-506) has been proven to be an efficient monotherapy for psoriasis, it doesn’t all the time work properly. Presently, mixture remedy is incessantly used to handle psoriasis as a result of scientific trials have proven it could present additive or synergistic advantages and cut back dangers of hostile results.
Myeloid-derived suppressor cells (MDSCs) have potent immunomodulatory and anti inflammatory properties in autoimmune illnesses. We beforehand reported that MDSCs had protecting results in a murine mannequin of imiquimod (IMQ)-induced psoriasis.
The current examine was undertaken to analyze the systemic immunomodulatory and therapeutic efficacy results of MDSC plus FK-506 in an IMQ-induced mouse mannequin of psoriasis and to analyze the immunomodulatory mechanisms concerned.
Systemic MDSC plus FK-506 remedy was discovered to have a big anti-psoriatic impact within the murine mannequin, to scale back ranges of pro-inflammatory cytokines Th1 cytokines (TNF-α and IFN-γ) and Th17 cytokines (IL-17A and IL-23) in serum and pores and skin. Nevertheless, therapy with MDSCs or FK-506 alone had little influence.
Moreover, the anti-psoriatic results of MDSC plus FK-506 have been related to histopathological reductions in inflammatory infiltration, epidermal hyperplasia, and hyperkeratosis.
As well as, this mixed therapy additionally attenuated IMQ-induced splenomegaly, and elevated the proportion of CD4+CD25+FoxP3+ regulatory T (Treg) cells and decreased the proportions of CD4+IFN-γ+ Th1 cells and CD4+IL-17+ Th17 cells in spleen.
Taken collectively, our outcomes present systemic mixture remedy with MDSCs and FK-506 had a greater therapeutic impact in our IMQ-induced psoriasis mannequin than both agent alone, and counsel that this combinatorial remedy may be helpful for the administration of autoimmune pores and skin illnesses like psoriasis.
 ELISA Kit)
Mouse Leukemia Inhibitory Factor (LIF) ELISA Kit 
anti-LIF  ELISA Kit)
Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit  ELISA Kit)
Canine Leukemia Inhibitory Factor (LIF) ELISA Kit  ELISA Kit)
Human Leukemia Inhibitory Factor (LIF) ELISA Kit  ELISA Kit)
Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit  ELISA Kit)
Rat Leukemia Inhibitory Factor (LIF) ELISA Kit 
Anti-LIF Antibody 
anti- LIF antibody 
Anti-LIF antibody 
Rabbit Polyclonal antibody Anti-CRBN 
LIF, Mouse 
LIF, mouse  antibody)
Anti-LIF (aa28-39) antibody 
Mouse LIF shRNA Plasmid 
Mouse LIF ELISA Kit 
Recombinant Mouse LIF Protein 
Polyclonal Goat anti-GST α-form 
Polyclonal Goat anti-GST μ-form 
Polyclonal Goat anti-GST p-form 
LIF protein 
LIF Antibody 
LIF antibody